Cathepsin cysteine protease inhibitors

Details for Australian Patent Application No. 2002254099 (hide)

Owner Axys Pharmaceuticals, Inc. Merck Frosst Canada Ltd.

Inventors Bayly, Christopher Ian; Setti, Eduardo L.; Palmer, James T.; Robichaud, Joel Stephane; Black, W. Cameron; Prasit, Petpiboon; Rydzewski, Robert M.

Agent Spruson & Ferguson

Pub. Number AU-B-2002254099

PCT Pub. Number WO2002/069901

Priority 60/272,799 02.03.01 US

Filing date 1 March 2002

Wipo publication date 19 September 2002

Acceptance publication date 6 July 2006

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-B-2002254099

16 March 2006 Assignment before Grant

  Axys Pharmaceuticals, Inc.; Merck Frosst Canada & Co. The application has been assigned to Axys Pharmaceuticals, Inc.; Merck Frosst Canada Ltd.

6 July 2006 Application Accepted

  Published as AU-B-2002254099

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254100-USER LOGIN DELEGATION

2002254098-SYSTEM FOR CONTROL OF ACTIVE SYSTEM FOR VIBRATION AND NOISE REDUCTION